NQO1 and ovarian cancer: In addition, the antioxidant enzyme NAD(P)H:quinone oxidoreductase 1 could regulate the response to chemotherapy in ovarian cancer [16], and the antioxidant-related gene NRF2 has been shown to be an indicator for the prognosis of ovarian cancer [17].